Research Directions | September 2023
25 September 2023Monthly insights on Australian and international MND research by our Executive Research Director, Dr Gethin Thomas – September 2023 edition.
Monthly insights on Australian and international MND research by our Executive Research Director, Dr Gethin Thomas – September 2023 edition.
The PBAC is currently accepting submissions regarding the inclusion of Edaravone (RADICAVA®) on the Pharmaceutical Benefits Scheme.
We are excited to announce the recipients of the Daniel McLoone Major Research Initiative jointly funded by MND Research Australia (MNDRA) and FightMND.
$46M
invested in research to find treatments and a cure for motor neurone disease
2,100
Australians currently living with MND who we support through investment in research, care and advocacy
148
evidence-based MND information materials developed to advance care and quality of life